Monsanto misses Street 2Q forecasts on falling seed sales
Monsanto Co. on Wednesday reported weaker-than-expected earnings for the second quarter amid flagging sales of the company's biotech-enhanced seeds and signature weed killer, Roundup.
Monsanto Co. on Wednesday reported weaker-than-expected earnings for the second quarter amid flagging sales of the company's biotech-enhanced seeds and signature weed killer, Roundup.